The Oman Companion Animal Infectious Disease Diagnostics Market is valued at USD 48 million, based on a five-year historical analysis. This growth is primarily driven by rising pet ownership, increasing expenditure on animal health, and heightened awareness among pet owners regarding the importance of early disease detection. The demand for accurate and timely diagnostics has surged, leading to advancements in diagnostic technologies and an increase in veterinary services. Recent trends also highlight the adoption of advanced molecular diagnostics and point-of-care testing, reflecting a broader shift toward preventive and precision veterinary care.Oman Companion Animal Infectious Disease Diagnostics Market is valued at USD 48 million, driven by rising pet ownership, increased health expenditure, and advanced diagnostic technologies.
Muscat, Salalah, and Sohar are the dominant cities in the Oman Companion Animal Infectious Disease Diagnostics Market. Muscat, as the capital, has the highest concentration of veterinary clinics and hospitals, while Salalah and Sohar are experiencing notable growth in pet ownership and veterinary service infrastructure, further contributing to market expansion.
In 2023, the Ministry of Agriculture, Fisheries and Water Resources issued the “Regulation on Veterinary Clinics and Laboratories, 2023,” mandating all veterinary clinics to implement standardized diagnostic protocols for infectious diseases in companion animals. This regulation requires clinics to maintain detailed diagnostic records, adhere to quality assurance standards, and ensure staff are trained in updated diagnostic procedures, thereby enhancing the quality and reliability of veterinary care across Oman.
Oman Companion Animal Infectious Disease Diagnostics Market Segmentation
By Type:
The market is segmented into serological tests, molecular diagnostics, rapid antigen/antibody tests, microbiology/bacteriology tests, parasitology diagnostics, and others. Among these, molecular diagnostics - particularly PCR and RT-PCR - are gaining significant traction due to their accuracy and rapid turnaround in detecting infectious diseases in companion animals. The increasing prevalence of zoonotic diseases, coupled with the need for rapid and reliable diagnosis, is driving demand for these advanced testing modalities. Additionally, point-of-care and portable diagnostic solutions are becoming more prevalent, supporting timely intervention and improved animal health outcomes.By End-User:
The end-user segmentation includes veterinary clinics, animal hospitals, diagnostic laboratories, research institutions, and pet owners utilizing home/self-testing kits. Veterinary clinics are the leading end-users, supported by the growing number of pet owners seeking regular health check-ups and diagnostics for their animals. The trend toward preventive healthcare and the adoption of advanced diagnostic tools in clinics and hospitals are further propelling demand. Diagnostic laboratories are also expanding their role, offering specialized and high-throughput testing services.Oman Companion Animal Infectious Disease Diagnostics Market Competitive Landscape
The Oman Companion Animal Infectious Disease Diagnostics Market is characterized by a dynamic mix of regional and international players. Leading participants such as IDEXX Laboratories, Inc., Zoetis Inc., Neogen Corporation, Virbac S.A., Heska Corporation, Abaxis, Inc., Biovet S.A., Randox Laboratories Ltd., Thermo Fisher Scientific Inc., QIAGEN N.V., IDEXX BioAnalytics, Vetoquinol S.A., BioNote, Inc., Fujifilm Wako Pure Chemical Corporation, and Bio-Rad Laboratories, Inc. contribute to innovation, geographic expansion, and service delivery in this space.Oman Companion Animal Infectious Disease Diagnostics Market Industry Analysis
Growth Drivers
Increasing Pet Ownership in Oman:
The pet ownership rate in Oman has surged, with approximately 65% of households now owning pets, up from 45% in 2018. This increase translates to over 1.8 million companion animals in the country. As pet ownership rises, the demand for diagnostic services to ensure animal health and well-being is expected to grow significantly, driving the market for infectious disease diagnostics in Oman.Rising Awareness of Animal Health:
Public awareness regarding animal health has improved, with 75% of pet owners now prioritizing regular veterinary check-ups. This shift is supported by educational campaigns from local veterinary associations, leading to a notable increase in the demand for diagnostic tests. The growing understanding of the importance of early disease detection is propelling the market for infectious disease diagnostics in Oman.Advancements in Diagnostic Technologies:
The introduction of innovative diagnostic technologies, such as rapid test kits and molecular diagnostics, has revolutionized the veterinary sector. In future, it is estimated that the adoption of these technologies will increase by 35%, enhancing the accuracy and speed of disease detection. This technological advancement is a key driver for the growth of the infectious disease diagnostics market in Oman.Market Challenges
Limited Access to Veterinary Services:
Despite the growing pet population, access to veterinary services remains a challenge, particularly in rural areas where only 45% of the population has access to veterinary clinics. This limited access hampers timely diagnosis and treatment of infectious diseases, posing a significant barrier to market growth in Oman.High Cost of Diagnostic Tests:
The cost of diagnostic tests can be prohibitive for many pet owners, with prices ranging from OMR 25 to OMR 120 per test. This financial barrier limits the frequency of testing and preventive care, which is crucial for managing infectious diseases. Consequently, the high cost of diagnostics presents a significant challenge to market expansion in Oman.Oman Companion Animal Infectious Disease Diagnostics Market Future Outlook
The future of the Oman companion animal infectious disease diagnostics market appears promising, driven by increasing pet ownership and advancements in veterinary care. The integration of telemedicine and point-of-care testing is expected to enhance service delivery, making diagnostics more accessible. Additionally, the growing trend towards preventive care will likely encourage pet owners to invest in regular health checks, further stimulating market growth. Collaborative efforts with international firms may also introduce innovative solutions to the local market.Market Opportunities
Growth in E-commerce for Pet Products:
The rise of e-commerce platforms in Oman presents a significant opportunity for the diagnostics market. With online sales of pet products projected to reach OMR 20 million in future, companies can leverage this trend to offer diagnostic services and products directly to consumers, enhancing accessibility and convenience.Expansion of Veterinary Clinics:
The establishment of new veterinary clinics is on the rise, with an expected increase of 30% in the number of clinics in future. This expansion will improve access to diagnostic services, allowing more pet owners to seek timely care for their animals, thereby driving demand for infectious disease diagnostics in Oman.Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- IDEXX Laboratories, Inc.
- Zoetis Inc.
- Neogen Corporation
- Virbac S.A.
- Heska Corporation
- Abaxis, Inc.
- Biovet S.A.
- Randox Laboratories Ltd.
- Thermo Fisher Scientific Inc.
- QIAGEN N.V.
- IDEXX BioAnalytics
- Vetoquinol S.A.
- BioNote, Inc.
- Fujifilm Wako Pure Chemical Corporation
- Bio-Rad Laboratories, Inc.

